Organogenesis Holdings Inc Net Income per Employee (ORGO), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Organogenesis Holdings Inc   (NASDAQ: ORGO)
 

Organogenesis Holdings Inc Net Income per Employee

ORGO's Quarterly Results, Trends, Rankings, Statistics
Organogenesis Holdings Inc recorded a cumulative net loss of $-10 million during 12 month ending in the first quarter 2026.
The Healthcare sector has seen employees of 76 other companies achieving higher income per employee. While Organogenesis Holdings Inc 's total ranking has deteriorated compared to the previous quarter from 1617 to 2566.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ORGO Net Income per Employee (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Net Income Change - 595.09 % 18.93 % - -
Net Income per Employee (TTM) $ -11,368 29,066 -14,744 -17,477 -23,296
ORGO's Total Ranking # 2566 # 1617 # 2399 # 2168 # 2444
Seq. Net Income Change - 197.99 % - - -

ORGO Company Profile >> Back to ORGO Efficiency Comparisons >> Compare ORGO Net Income per Employee to its Competitors

ORGO Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 77
Healthcare Sector # 237
Overall Market # 2566

Net Income per Employee Statistics
High Average Low
$ 111,126 $ 14,738 $ -48,128
(Dec 31 2021)   (Mar 31 2020)




  News about Organogenesis Holdings Inc Income per employee

Navigating Challenges and Opportunities: Organogenesisn Strategic Shift Amidst Financial Struggles

In recent developments, Organogenesis Holdings Inc. has been actively involved in promoting data-driven policies for Local Coverage Determination (LCD), positioning itself at the forefront of collaborative efforts aimed at enhancing the healthcare landscape. While this initiative highlights the companyns commitment to innovation and improved patient outcomes, it comes against a backdrop of significant financial challenges. Key Facts:1. Financial Performance: Organogenesis posted a cumulative net loss of $17 million for the 12 months ending in the second quarter of 2024. This loss raises concerns about the companyns ability to sustain operations and regain profitability amidst stiff competition within the pharmaceutical industry.




Companies with similar Income per Employee for 12 month ending Mar 31 2026, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2026Number of Employees Mar 31 2026


Date modified: 2026-08-29T17:37:45+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.